Loading clinical trials...
Loading clinical trials...
The changes of target and organs at risk in patients with high-grade glioma during concurrent chemoradiotherapy were evaluated by MRI image between radiotherapy fractions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
West China Hospital
NCT06829173 · High-Grade Glioma
NCT06624371 · High-grade Glioma, Medulloblastoma, and more
NCT06660056 · High-grade Gliomas
NCT06763965 · Recurrent High-grade Glioma
NCT07532031 · High-Grade Glioma, Glioblastoma, and more
West China Hospital
Chengdu, Sichuan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions